Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$181.44 - $260.22 $362 - $520
2 Added 25.0%
10 $2,000
Q3 2023

Nov 14, 2023

SELL
$240.69 - $338.77 $33,455 - $47,089
-139 Reduced 94.56%
8 $1,000
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $35,571 - $45,071
131 Added 818.75%
147 $50,000
Q1 2023

May 12, 2023

SELL
$220.43 - $278.69 $881 - $1,114
-4 Reduced 20.0%
16 $4,000
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $3,037 - $4,570
20 New
20 $4,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.